News
Ticagrelor noninferior to clopidogrel in terms of major bleeds in STEMI
March 11, 2018
New STEMI data answer some but not all questions.
Video
Post-ACS death lowered in ODYSSEY Outcomes
March 10, 2018
ORLANDO – Mortality and major adverse cardiovascular events were cut 15%, but that’s not all.
Article
A simplified risk prediction model for patients presenting with acute pulmonary embolism
February 21, 2018
Is there a simplified risk prediction model to identify those with low risk pulmonary embolism (PE) who can be treated as outpatients?
Article
Anticoagulation use in new-onset secondary atrial fibrillation
February 16, 2018
Is anticoagulant use in patients with new-onset atrial fibrillation secondary to acute coronary syndrome, acute pulmonary disease, or sepsis associated with a reduction in ischemic stroke or an increase in bleeding risk?
Article
Rivaroxaban versus warfarin in mild acute ischemic stroke secondary to atrial fibrillation
February 12, 2018
Clinical question: Is rivaroxaban as effective and safe as warfarin immediately following minor acute ischemic stroke from atrial fibrillation?
News
Controversy surrounds calf vein thrombosis treatment
January 30, 2018
CHICAGO – Anticoagulation, filter, or surveillance? Large retrospective study provides answers.
News
Triple therapy in question
January 16, 2018
Clinical question: In patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention (PCI), is dabigatran plus a P2Y12 inhibitor safer than, and as efficacious as, triple therapy with warfarin?
News
Rivaroxaban lowers cardiovascular risk but increases bleeding risk
January 16, 2018
Is rivaroxaban alone or in combination with aspirin more effective than is aspirin alone in preventing cardiovascular events in patients with stable atherosclerotic disease?
News
Idarucizumab reverses anticoagulation effects of dabigatran
December 14, 2017
Can idarucizumab reverse anticoagulation effects of dabigatran in a timely manner for urgent surgery or in the event of bleeding?
News
Guideline preview: ASH to recommend against VTE prophylaxis for lower-risk cancer patients
December 10, 2017
ATLANTA – ASH attendees got a preview of forthcoming recommendations on prevention and treatment of VTE in patients with cancer.